Wave Life Sciences

WVENasdaq Singapore Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$838.440 M

$4.26 -2.18%

Close of 21 Sept 2026

Revenue

$42.7M

#2781 by revenue

Earnings

-$204.4M

Loss-making

Shares outstanding

197,048,175

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#170CybinHELP$846.7M
#171Olema PharmaceuticalsOLMA$842.6M
#172Wave Life SciencesWVE$838.4M
#173GeronGERN$835.2M
#174Gyre TherapeuticsGYRE$828.5M

What if Wave Life Sciences were worth as much as…

Open the what-if tool →

Gold $30.3T

$153,637.83

Per share 36,108× higher

Bitcoin $1.72T

$8,727.83

Per share 2,051× higher

Nvidia $5.48T

$27,809.74

Per share 6,536× higher

Or at a round number

$2.00B $5.00B $10.0B $20.0B

Where these numbers come from

Share counts and financials for Wave Life Sciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.